MAP2K2 and cardiofaciocutaneous syndrome: To investigate mechanisms by which distinct activating MEK mutations differentially induce CFC or cancer we used Q56P-MEK1 or Q60P-MEK2 that were mainly linked to cancer, and Y130C-MEK1 or Y134C-MEK2 that were found only in CFC.